Poul Sorensen

Dr. Sorensen uses a combination of genetic and biochemical approaches to identify and discover proteins that are specifically altered in childhood cancers and adult breast tumours. His initial discoveries have been translated by FUSION GENOMICS into new diagnostic tests for specific tumours, and have advanced their understanding of how the involved proteins transmit signals that cause cells to become cancerous. Dr. Sorensen is also the Chair of the Translational Research Committee of the Children’s Oncology Group (COG), the largest pediatric oncology clinical trials network in the world.